These studies investigated the use of GLP-1 RAs, specifically exenatide (EXE) (n = 3) [30,33,37] and liraglutide (LIRA) (n = 5) [31,32,34-36], in patients diagnosed with PCOS. Here, GCG is linked to polycystic ovary syndrome.